Education
About Us
Working with TipRanks
Follow Us
Hyperfine (HYPR)
NASDAQ:HYPR
HYPR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.76 - $1.90
Previous CloseN/A
Volume18.70K
Average Volume (3M)1.87M
Market Cap
$71.19M
Enterprise Value$32.62M
Total Cash (Recent Filing)$37.65M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.34
Next Earnings
May 08, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding62,404,736
10 Day Avg. Volume4,175,570
30 Day Avg. Volume1,871,299
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.06
Price to Cash Flow (P/CF)-2.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.46
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.54
Enterprise Value/Ebitda-0.77
Forecast
1Y Price Target
$1.25Price Target Upside-2.34% Downside
Rating ConsensusHold
Number of Analyst Covering2
---
Hyperfine News
PremiumCompany Announcements
Hyperfine Inc. Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Hyperfine, Inc. Reports 2024 Financial Results and Strategic Expansion
PremiumCompany Announcements
Hyperfine Achieves Key Milestones for 2025 Growth---
Bulls Say, Bears Say
Bulls Say
Growth DriversManagement pointed to several new growth drivers in the second half of the year.
Installation PerformanceThe company installed 13 new systems, above expectation of 10 at an ASP of $233K.
PartnershipsHYPR is partnering with NVIDIA to develop future technologies that incorporate NVIDIA's advanced artificial intelligence (AI) capabilities with the Swoop system.
Product LaunchHYPR expects to accelerate the launch in neurology offices, noting positive feedback from early pilot centers.
Bears Say
Market EnvironmentHYPR reported Q3 revenues ahead of expectations and tightened 2024 guidance to $14-14.5M revenue.
Sales CycleThe company is seeing an elongation in their selling cycle, as compared to prior quarters, due to a softer capital environment for US hospitals.
---
Ownership Overview
27.65% Insiders
6.20% Mutual Funds
8.33% Other Institutional Investors
52.92% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HYPR FAQ
What was Hyperfine’s price range in the past 12 months?
Hyperfine lowest stock price was $0.76 and its highest was $1.90 in the past 12 months.
What is Hyperfine’s market cap?
Hyperfine’s market cap is $71.19M.
When is Hyperfine’s upcoming earnings report date?
Hyperfine’s upcoming earnings report date is May 08, 2025 which is in 50 days.
How were Hyperfine’s earnings last quarter?
Hyperfine released its earnings results on Mar 17, 2025. The company reported -$0.14 earnings per share for the quarter, the consensus estimate of -$0.14 by $0.
Is Hyperfine overvalued?
According to Wall Street analysts Hyperfine’s price is currently Overvalued.
Does Hyperfine pay dividends?
Hyperfine does not currently pay dividends.
What is Hyperfine’s EPS estimate?
Hyperfine’s EPS estimate is -0.12.
How many shares outstanding does Hyperfine have?
Hyperfine has 62,404,736 shares outstanding.
What happened to Hyperfine’s price movement after its last earnings report?
Hyperfine reported an EPS of -$0.14 in its last earnings report, expectations of -$0.14. Following the earnings report the stock price went down -28.906%.
Which hedge fund is a major shareholder of Hyperfine?
Currently, no hedge funds are holding shares in HYPR
---
Hyperfine Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.25 (-2.34% Downside)
$1.25 (-2.34% Downside)
Blogger Sentiment
Bullish
HYPR Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $3.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
8.47%
12-Months-Change
Fundamentals
Return on Equity
-53.93%
Trailing 12-Months
Asset Growth
-32.68%
Trailing 12-Months
Company Description
Hyperfine
HealthCor Catalio Acquisition Corp is a blank check company.
---
HYPR Company Deck
---
HYPR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Hyperfine showed strong revenue growth and improved gross margins, reduced its cash burn, and demonstrated strategic expansion into international and office markets. However, it faced challenges with decreased quarterly revenue, U.S. sales delays, and continued net losses. The positive aspects were balanced with significant challenges.Read More>---
HYPR Stock 12 Month Forecast
Average Price Target
$1.25
▼(-2.34% Downside)
Technical Analysis
Best Analysts Covering HYPR
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
+0.55%
reiterated a buy rating 7 months ago
Copying Yuan Zhi's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +0.55% per trade.
---